Current Research into Cures for Type-1 Diabetes

This blog posting is a summary of four small updates.  Unfortunately, they include research delay, two unsuccessful trials, and one trial un...

Ustekinumab was approved in the US in 2009 for treating psoriasis, which is an autoimmune disease (where the immune system self attacks ski...

Exsulin is a drug designed to trigger beta cell growth and Ustekinumab is designed to modulate the immune system.  These researchers are te...

This is a quick summary of all of the new clinical trials into type-1 that started between October 1st, 2012 and January 1st, 2013. These a...

Based on my last couple of posts, I got the two following questions: How is the phase-II Exsulin study that is currently underway, differe...

Exsulin's Phase-II Trial is Data Complete  The exact update I got on the Exsulin phase-II trial is this: "We have finished recrui...

Diamyd Finishes Enrollment of their European Phase-III Trial Diamyd has finished enrolling patients in their 300 person, phase-III Europea...

The Exsulin company is hoping to start Phase-I human trials in June 2009 (so right soon now). They are testing a new formulation of INGAP ...

DiaKine is about to start it's first clinical trial in a research program aimed at curing type-1 diabetes. Their treatment is Lisofylli...